Juvenile Hemochromatosis due to a Homozygous Variant in the HJV Gene

Hemochromatosis type 2 or juvenile hemochromatosis has an early onset of severe iron overload resulting in organ manifestation such as liver fibrosis, cirrhosis, cardiomyopathy, arthropathy, hypogonadism, diabetes, osteopathic medicine, and thyroid abnormality, before age of 30. Juvenile hemochromat...

Full description

Saved in:
Bibliographic Details
Main Authors: María-Belén (Author), Manuel Méndez (Author), María-Isabel (Author), Ana-María (Author), José-Manuel (Author), María-José (Author)
Format: Book
Published: Hindawi Limited, 2022-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_e91b9fcbb19c4f32b7397fc33ef4c9a8
042 |a dc 
100 1 0 |a María-Belén   |e author 
700 1 0 |a Manuel Méndez  |e author 
700 1 0 |a María-Isabel   |e author 
700 1 0 |a Ana-María  |e author 
700 1 0 |a José-Manuel   |e author 
700 1 0 |a María-José  |e author 
245 0 0 |a Juvenile Hemochromatosis due to a Homozygous Variant in the HJV Gene 
260 |b Hindawi Limited,   |c 2022-01-01T00:00:00Z. 
500 |a 2090-6811 
500 |a 10.1155/2022/7743748 
520 |a Hemochromatosis type 2 or juvenile hemochromatosis has an early onset of severe iron overload resulting in organ manifestation such as liver fibrosis, cirrhosis, cardiomyopathy, arthropathy, hypogonadism, diabetes, osteopathic medicine, and thyroid abnormality, before age of 30. Juvenile hemochromatosis type 2a and 2b is an autosomal recessive disease caused by pathogenic variants in HJV and HAMP genes, respectively. We report a child with hepatic iron overload and family history of hemochromatosis. We aim to raise awareness of juvenile hemochromatosis, especially in families with a positive family history, as early diagnosis and treatment may prevent organ involvement and end-stage disease. The purpose of this study was to identify the gene variant that causes the disease. The genetic study was performed with a targeted gene panel: HFE, HJV, HAMP, TFR2, SLC40A1, FTL, and FTH1. We identified the variant c.309C > G (p.Phe103Leu) in the HJV gene in the homozygous state in the patient. 
546 |a EN 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Case Reports in Pediatrics, Vol 2022 (2022) 
787 0 |n http://dx.doi.org/10.1155/2022/7743748 
787 0 |n https://doaj.org/toc/2090-6811 
856 4 1 |u https://doaj.org/article/e91b9fcbb19c4f32b7397fc33ef4c9a8  |z Connect to this object online.